arrow
M

Mundanattu Swetha

rajiv gandhi centre for biotechnology
H指数:6
被引数:209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3

乌特罗西德B,一种美国FDA指定的‘孤儿药’,通过EGFR/ERK介导的SREBP-1和STAT-3抑制,减轻肝细胞癌及其肺转移的发展

2026-04-160
OAAI
Orphan drug Uttroside B Impedes NASH Progression and HCC Development in Experimental Models

孤儿药Uttroside B在实验模型中阻碍NASH进展和HCC发展

2025-10-100
OAAI
Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy (vol 11, 656804, 2021)
2023-12-150
OAAI
Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma (vol 12, 812598, 2022)
2022-08-250
OAAI
Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential (vol 12, 903832, 2022)
2022-08-120
OAAI
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling
2022-08-108
PRE
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
2022-06-087
OAAI
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
2022-05-226
OAAI
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma
2022-02-087
OAAI
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy
2021-07-1512
OAAI